Biosimilars

The AJMC^® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.

Latest News

FDA Approved. | Image Credit: Nirusmee - stock.adobe.com

First Insulin Aspart Biosimilar Receives FDA Approval

By Cameron Santoro

February 20th 2025

Merilog (insulin-aspart-szjj) is the first rapid-acting insulin biosimilar to Novolog (insulin aspart) that is designated to improve glycemic control in adults and adolescents with type 2 diabetes.

Osteoporosis. | Image Credit: Nisit - stock.adobe.com

Denosumab Biosimilars Approved With Interchangeability to Address Osteoporosis, Fracture Risk

By Cameron Santoro

February 18th 2025

Insulin. | Image Credit: Sherry Young- stock.adobe.com

Biosimilar Insulin Linked to Lower Prices in Europe

By Cameron Santoro

February 12th 2025

FDA approved. | Image Credit: Olivier Le Moal - stock.adobe.com

FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra

By Cameron Santoro

January 31st 2025

Kirollos Hanna, PharmD

Embracing EOM, Enhancing Collaboration and Cost Management: Dr Kirollos Hanna

By Kyle Munz
Kirollos Hanna, PharmD

January 29th 2025

Continuing Medical Education

March 3rd 2025

New and Approved: FDA’s 2024 Drug Lineup

1.5 Credits / General Pharmacy

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions